Amneal Pharmaceuticals, Inc.

Of course, my daughter sent me a picture.

Hello, and welcome to the AMNEO first quarter 2021 conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touchtone phone. To withdraw your question, please press star then two. Please note, today's event is being recorded. I would now like to call over to AMNEO's head of investor relations, Tony DiMeo.

Good morning, and thank you for joining us for AMNIL's first quarter 2021 earnings call. Earlier this morning, we issued a press release reporting our financial results. The press release, as well as the slides that will be presented on this call, are available on our website at amnil.com. We are conducting a live webcast of this call, a replay of which will also be available on our website after its conclusion. Please note that today's call is copyrighted material to AMNIL. and cannot be rebroadcast without the company's express written consent. I would like to remind you that statements made during this call stating management's outlook or predictions for future periods are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Cautionary Statements on Forward-Looking Statements in our press release and presentation which applies to this call. Our future performance may differ due to numerous factors, many of which are listed on our most recent annual report on Form 10-K and are revised and updated on our quarterly reports on Form 10-Q and current reports on Form 8-K, which you can also find on our website and on the SEC's website at sec.gov. We also discussed certain non-GAAP measures. You will find important information on our use of these measures and our reconciliations to U.S. GAAP in our earnings release. Included in the appendix of today's presentation, you will find U.S. GAAP financial metrics that correspond to some of our U.S. non-GAAP measures we referenced throughout the presentation. On the call this morning are Chirag and Shintu Patel, our co-CEOs, Tasos Conideras, our CFO, Andy Boyer and Joe Jadisco, our chief commercial officers for the generics and specialty segments. and Steve Manzano, our General Counsel and Corporate Secretary. I will now turn the call over to Shirag.